National Council for Prescription Drug Programs indexing - billing unit

Manufacturer: National Council for Prescription Drug Programs
Effective date: 2012-07-24
Label type: Indexing - Billing Unit
Version: 1
Source: full-release
Hydrated at: 2026-06-05 02:21:17

Label at a glance#

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
42747-221-32	EA - Each	42747-221	9fb4cf87-cf43-4866-9771-e848d65ea4b9	1	2012-07-24

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
42747-221	42747-221-32

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 6 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	RLD / RS	Approval date
N022510-001	ABSTRAL	FENTANYL CITRATE	EQ 0.1MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07
N022510-002	ABSTRAL	FENTANYL CITRATE	EQ 0.2MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07
N022510-003	ABSTRAL	FENTANYL CITRATE	EQ 0.3MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07
N022510-004	ABSTRAL	FENTANYL CITRATE	EQ 0.4MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07
N022510-005	ABSTRAL	FENTANYL CITRATE	EQ 0.6MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07
N022510-006	ABSTRAL	FENTANYL CITRATE	EQ 0.8MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 7 · 258 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N022510-001	ABSTRAL	EQ 0.1MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022510-002	ABSTRAL	EQ 0.2MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022510-003	ABSTRAL	EQ 0.3MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022510-004	ABSTRAL	EQ 0.4MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022510-005	ABSTRAL	EQ 0.6MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N022510-006	ABSTRAL	EQ 0.8MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N022510-001	ABSTRAL	EQ 0.1MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022510-002	ABSTRAL	EQ 0.2MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022510-003	ABSTRAL	EQ 0.3MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022510-004	ABSTRAL	EQ 0.4MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022510-005	ABSTRAL	EQ 0.6MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N022510-006	ABSTRAL	EQ 0.8MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N022510-001	ABSTRAL	EQ 0.1MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022510-002	ABSTRAL	EQ 0.2MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022510-003	ABSTRAL	EQ 0.3MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022510-004	ABSTRAL	EQ 0.4MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022510-005	ABSTRAL	EQ 0.6MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022510-006	ABSTRAL	EQ 0.8MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022510-001	ABSTRAL	EQ 0.1MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022510-002	ABSTRAL	EQ 0.2MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022510-003	ABSTRAL	EQ 0.3MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022510-004	ABSTRAL	EQ 0.4MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022510-005	ABSTRAL	EQ 0.6MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022510-006	ABSTRAL	EQ 0.8MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N022510-001	ABSTRAL	EQ 0.1MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N022510-002	ABSTRAL	EQ 0.2MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N022510-003	ABSTRAL	EQ 0.3MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N022510-004	ABSTRAL	EQ 0.4MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N022510-005	ABSTRAL	EQ 0.6MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N022510-006	ABSTRAL	EQ 0.8MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022510-001	ABSTRAL	EQ 0.1MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022510-002	ABSTRAL	EQ 0.2MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022510-003	ABSTRAL	EQ 0.3MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022510-004	ABSTRAL	EQ 0.4MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022510-005	ABSTRAL	EQ 0.6MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022510-006	ABSTRAL	EQ 0.8MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022510-001	ABSTRAL	EQ 0.1MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022510-002	ABSTRAL	EQ 0.2MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022510-003	ABSTRAL	EQ 0.3MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022510-004	ABSTRAL	EQ 0.4MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TABLET / SUBLINGUAL	RLD	2011-01-07	`b8a1b40f171c…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-09-15 20:21 UTC	2019-09	N022510-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N022510-002	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N022510-003	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N022510-004	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N022510-005	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N022510-006	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N022510-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N022510-002	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N022510-003	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N022510-004	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N022510-005	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N022510-006	AB	1	`ea99ee380514…`

Observed Orange Book patent history#

Patent history page 1 of 2 · 72 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N022510-001	6759059	2019-09-24	U-767	Drug product		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N022510-001	6761910	2019-09-24	U-767	Drug product		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N022510-001	7910132	2019-09-24	U-767	Drug product	2011-04-01	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N022510-002	6759059	2019-09-24	U-767	Drug product		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N022510-002	6761910	2019-09-24	U-767	Drug product		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N022510-002	7910132	2019-09-24	U-767	Drug product		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N022510-003	6759059	2019-09-24	U-767	Drug product		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N022510-003	6761910	2019-09-24	U-767	Drug product		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N022510-003	7910132	2019-09-24	U-767	Drug product		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N022510-004	6759059	2019-09-24	U-767	Drug product		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N022510-004	6761910	2019-09-24	U-767	Drug product		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N022510-004	7910132	2019-09-24	U-767	Drug product		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N022510-005	6759059	2019-09-24	U-767	Drug product		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N022510-005	6761910	2019-09-24	U-767	Drug product		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N022510-005	7910132	2019-09-24	U-767	Drug product		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N022510-006	6759059	2019-09-24	U-767	Drug product		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N022510-006	6761910	2019-09-24	U-767	Drug product		`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N022510-006	7910132	2019-09-24	U-767	Drug product		`74a2ff9319b5…`
2019-12-14 00:12 UTC	2019-12	N022510-001	6759059	2019-09-24	U-767	Drug product		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N022510-001	6761910	2019-09-24	U-767	Drug product		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N022510-001	7910132	2019-09-24	U-767	Drug product	2011-04-01	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N022510-002	6759059	2019-09-24	U-767	Drug product		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N022510-002	6761910	2019-09-24	U-767	Drug product		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N022510-002	7910132	2019-09-24	U-767	Drug product		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N022510-003	6759059	2019-09-24	U-767	Drug product		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N022510-003	6761910	2019-09-24	U-767	Drug product		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N022510-003	7910132	2019-09-24	U-767	Drug product		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N022510-004	6759059	2019-09-24	U-767	Drug product		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N022510-004	6761910	2019-09-24	U-767	Drug product		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N022510-004	7910132	2019-09-24	U-767	Drug product		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N022510-005	6759059	2019-09-24	U-767	Drug product		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N022510-005	6761910	2019-09-24	U-767	Drug product		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N022510-005	7910132	2019-09-24	U-767	Drug product		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N022510-006	6759059	2019-09-24	U-767	Drug product		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N022510-006	6761910	2019-09-24	U-767	Drug product		`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N022510-006	7910132	2019-09-24	U-767	Drug product		`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N022510-001	6759059	2019-09-24	U-767	Drug product		`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N022510-001	6761910	2019-09-24	U-767	Drug product		`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N022510-001	7910132	2019-09-24	U-767	Drug product	2011-04-01	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N022510-002	6759059	2019-09-24	U-767	Drug product		`b00525d2431f…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.